The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, Italy by Vieri Lastrucci, Martina Pacifici, Giorgia Alderotti, Monia Puglia, Elettra Berti, Federica Barbati, Lorenzo Lodi, Lorenzo Lodi, Silvia Boscia, Francesco Nieddu, Giuseppe Indolfi, Giuseppe Indolfi, Diego Peroni, Marco Martini, Chiara Azzari, Chiara Azzari, Fabio Voller, Maria Moriondo, Silvia Ricci, Silvia Ricci

Get full text